肝硬化患者经历歧视与医疗不信任的多中心调查
该研究在美国4个大型医疗系统前瞻性纳入3357例肝硬化患者,1037例完成包含歧视经历量表和群体医疗不信任量表的调查。27.1%报告经历歧视,9.8%报告高医疗不信任;黑人患者报告频繁歧视和高不信任的比例显著高于白人和西班牙裔。歧视或不信任与住院、失代偿或死亡的复合结局无显著关联。
要点
- 肝硬化患者中27.1%报告经历歧视,9.8%报告高医疗不信任。
- 黑人患者报告频繁歧视(40.5%)和高不信任(22.3%)的比例最高。
- 黑人种族与歧视评分最高四分位(OR 4.37)和高不信任(OR 3.59)独立相关。
核心结论
- 经历歧视和医疗不信任在黑人肝硬化患者中常见,解决这些因素可能有助于减轻诊疗中的种族和民族不平等。
研究设计与样本
- 前瞻性多中心队列研究,在美国4个大型医疗系统纳入3357例肝硬化患者,其中1037例(30.9%)完成调查。
- 使用经验歧视量表和群体医疗不信任量表(GBMMS)进行验证调查,采用单变量和多变量回归分析。
主要发现
- 总体27.1%报告经历歧视,9.8%报告高医疗不信任(GBMMS≥3)。
- 黑人患者报告频繁歧视的比例为40.5%,高于西班牙裔的22.2%和白人的18.7%(P<.001)。
- 黑人患者报告高不信任的比例为22.3%,高于白人的6.8%和西班牙裔的4.2%(P<.001)。
- 多变量分析中,黑人种族(OR 4.37; 95%CI 2.49-7.67)和西班牙裔(OR 1.85; 95%CI 1.06-3.25)与歧视评分最高四分位相关。
- 黑人种族与高不信任独立相关(OR 3.59; 95%CI 2.05-6.29),而歧视或不信任与住院、失代偿或死亡的复合结局无显著关联。
关键数值与推荐
- 高医疗不信任定义为GBMMS评分≥3。
- 歧视评分最高四分位作为结局,黑人种族OR 4.37(95%CI 2.49-7.67),西班牙裔OR 1.85(95%CI 1.06-3.25)。
临床怎么用
- 消化内科医生应关注肝硬化患者中歧视经历和医疗不信任,尤其针对黑人患者。
- 解决这些因素可能有助于减少诊疗障碍和改善肝硬化患者的结局。
局限性
- 调查应答率为30.9%,可能存在无应答偏倚。
- 横断面调查设计无法确定因果关系。
- 歧视和不信任与临床复合结局无显著关联,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Medical mistrust and experiences of discrimination contribute to racial and ethnic disparities in clinical outcomes for several health conditions; however, the prevalence of these constructs remain understudied in patients with cirrhosis. METHODS: We prospectively enrolled patients with cirrhosis to complete surveys at 4 large U.S. health systems. We administered validated surveys including the Experiences of Discrimination measure and the Group-Based Medical Mistrust Scale (GBMMS). Univariable and multivariable regression models were used to examine associations of race and ethnicity with patient-reported discrimination and medical mistrust. RESULTS: Among 3357 patients, 1037 (30.9%) completed the survey (43.4% White, 22.4% Black, 30.2% Hispanic; median age 61.3 years, 63.0% men). Overall, 27.1% of patients reported experiencing discrimination and 9.8% reported high medical mistrust (GBMMS ≥3). More Black patients reported frequent discrimination (40.5%) compared with Hispanic (22.2%) and White (18.7%) patients (P < .001). In multivariable analysis, compared with White race, Black race (odds ratio [OR], 4.37; 95% confidence interval [CI], 2.49-7.67) and Hispanic ethnicity (OR, 1.85; 95% CI, 1.06-3.25) were associated with the top quartile of discrimination scores. Similarly, 22.3% of Black patients reported high mistrust compared with 6.8% and 4.2% of White and Hispanic patients, respectively (P < .001). Black patients continued to be more likely than White patients to report high mistrust in multivariable models (OR, 3.59; 95% CI, 2.05-6.29). There were no statistically significant associations between higher levels of discrimination or mistrust and the composite outcome of hospitalization, decompensation, or death. CONCLUSIONS: Experienced discrimination and medical mistrust are common among Black patients with cirrhosis. Addressing these factors may mitigate racial and ethnic inequities in care, reduce barriers to care, and improve outcomes for patients with cirrhosis.
引用
- Rich NE, Kramer JR, Liu Y, et al. Experienced Discrimination and Medical Mistrust Among Patients With Cirrhosis: Survey Results From a Multicenter Cohort. Clin Gastroenterol Hepatol. 2025. PMID: 41076045. doi:10.1016/j.cgh.2025.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。